GlassScriptPhysician profile
Gail M Sobel
NPI 1477533750
$618.99
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $65.07 · 2021: $105 · 2022: $194.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $104.51 | 2019-2022 | |
| Pfizer INC. | $86.81 | 2019-2022 | |
| Therapeuticsmd, INC. | $52.95 | 2019-2021 | |
| Allergan, INC. | $51.01 | 2019 | |
| Millicent US INC | $44.39 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $42.98 | 2019-2020 | |
| Lupin INC. | $42.00 | 2019-2021 | |
| Evofem Biosciences, INC. | $39.53 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $30.59 | 2022 | |
| Exeltis, USA INC. | $24.98 | 2021-2022 | |
| Avion Pharmaceuticals | $24.20 | 2019-2021 | |
| Hologic Sales and Service, LLC | $23.80 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.76 | 2022 | |
| Myovant Sciences INC. | $15.00 | 2022 | |
| Coopersurgical, INC. | $13.48 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Sobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.